Tag: Clinical Data
ArQule (ARQL) Stock: Rocketing On Clinical Data
ArQule, Inc. (NASDAQ: ARQL) is having a great start to the trading session this morning, and for good reason. The company announced preliminary results...
La Jolla Pharmaceutical (LJPC) Stock: Continuing Its Run For The Top
La Jolla Pharmaceutical Company (NASDAQ: LJPC) is climbing in the market yet again today, following up on the incredible gains that the stock saw...
Actinium Pharmaceuticals (ATNM) Stock: Climbing On New Pivotal Data
Actinium Pharmaceuticals Inc (NYSEAMERICAN: ATNM) is headed up early on in the trading session with gains of more than 6% just after the opening...
Genocea Biosciences (GNCA) Stock: Cancer Vaccine Data Leads To Gains
Genocea Biosciences Inc (NASDAQ: GNCA) is grabbing the attention of investors this morning after announcing data from an early-stage clinical trial assessing a cancer...
Cara Therapeutics (CARA) Stock: Flying On Clinical Data
Cara Therapeutics Inc (NASDAQ: CARA) is having an incredibly strong start to the trading session this morning, and for good reason. The company released...
Armata Pharmaceuticals (ARMP) Stock: Up Big On Clinical Data Publication
Armata Pharmaceuticals Inc (NYSEAMERICAN: ARMP) is climbing in the market this morning, and for good reason. The company announced the publication of positive clinical...
Neovasc (NVCN) Stock: Climbing On Data Publication
Neovasc Inc (NASDAQ: NVCN) is seeing overwhelming gains in value early this morning, and for good reason. In the afterhours session yesterday, the comapny...
BioCryst Pharmaceuticals (BCRX) Stock: Falling Hard After Positive Study Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is having an overwhelmingly rough start in the premarket hours this morning, leaving many wondering why. The company released...
Achillion Pharmaceuticals (ACHN) Stock: Climbing On Clinical Data
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced...
Cellectar Biosciences (CLRB) Stock: Gaining On CLR 131 Update
Cellectar Biosciences Inc (NASDAQ: CLRB) is having an incredibly strong start to the trading session this morning, and for good reason. The company provided...
Bristol-Myers Squibb (BMY) Stock: Spiking On Rumor Of PFE Takeover
Bristol-Myers Squibb Co (NYSE: BMY) is is experiencing a relatively strong spike in the market at the moment, and for good reason. There are...
Reviews
TradeMiner Review: Is It Worth Your While?
There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...
